Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 4Active not recruiting 3Recruiting 2Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3

Conditions

Carcinoma, Non-Small-Cell Lung 85Breast Neoplasms 37Lung Neoplasms 27Triple Negative Breast Neoplasms 25Ovarian Neoplasms 21Squamous Cell Carcinoma of Head and Neck 20Fallopian Tube Neoplasms 16Small Cell Lung Carcinoma 15Neoplasm Metastasis 14Endometrial Neoplasms 13Esophageal Neoplasms 11Neoplasms 10Prostatic Neoplasms 9Colorectal Neoplasms 9Head and Neck Neoplasms 8Carcinoma 8Urinary Bladder Neoplasms 7Uterine Cervical Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Pancreatic Neoplasms 6Oropharyngeal Neoplasms 6Lymphoma, Large B-Cell, Diffuse 6Laryngeal Neoplasms 5Carcinoma, Transitional Cell 5Carcinoma, Squamous Cell 5Stomach Neoplasms 4Mouth Neoplasms 4Melanoma 4Carcinoma, Ovarian Epithelial 4Urothelial Cancer 3

Interventions

pembrolizumab 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Docetaxel 3Cisplatin 3Carboplatin 3entrectinib 2Radiotherapy, Intensity-Modulated 2Platinum 2Biopsy 21,2-diaminocyclohexaneplatinum II citrate 2trastuzumab deruxtecan 1luprolide acetate gel depot 1lenvatinib 1dehydroftorafur 1darolutamide 1ceralasertib 1apalutamide 1amivantamab 1X-Rays 1Surveys and Questionnaires 1Radiotherapy, Conformal 1Radiosurgery 1Pemetrexed 1Leuprolide 1Immunoglobulin G 1Gonadotropin-Releasing Hormone 1Glutamate Carboxypeptidase II 1Fluorouracil 1EBC-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Salivary Gland Neoplasms × Carboplatin × Clear all
NCT00588770 2026-05-29

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 3 Active not recruiting
403 enrolled 10 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT03781986 2026-03-03

APG-115 in Salivary Gland Cancer Trial

University of Michigan Rogel Cancer Center

Phase 1/2 Active not recruiting
41 enrolled
Head & Neck

Carcinoma, Adenoid Cystic, Salivary Gland Neoplasms

NCT05010629 2025-05-31

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Dana-Farber Cancer Institute

Phase 2 Active not recruiting
35 enrolled
Head & Neck

Carcinoma, Adenoid Cystic, Neoplasm Metastasis, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡